Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis

被引:0
作者
Helene M. Ægidius
Sanne S. Veidal
Michael Feigh
Philip Hallenborg
Michele Puglia
Tune H. Pers
Niels Vrang
Jacob Jelsing
Birgitte R. Kornum
Blagoy Blagoev
Kristoffer T. G. Rigbolt
机构
[1] Gubra,
[2] Hørsholm Kongevej 11B,undefined
[3] Department of Biochemistry and Molecular Biology,undefined
[4] University of Southern Denmark,undefined
[5] Novo Nordisk Foundation Center for Basic Metabolic Research,undefined
[6] University of Copenhagen,undefined
[7] Department of Neuroscience,undefined
[8] University of Copenhagen,undefined
来源
Scientific Reports | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
To improve the understanding of the complex biological processes underlying the development of non-alcoholic steatohepatitis (NASH), a multi-omics approach combining bulk RNA-sequencing based transcriptomics, quantitative proteomics and single-cell RNA-sequencing was used to characterize tissue biopsies from histologically validated diet-induced obese (DIO) NASH mice compared to chow-fed controls. Bulk RNA-sequencing and proteomics showed a clear distinction between phenotypes and a good correspondence between mRNA and protein level regulations, apart from specific regulatory events discovered by each technology. Transcriptomics-based gene set enrichment analysis revealed changes associated with key clinical manifestations of NASH, including impaired lipid metabolism, increased extracellular matrix formation/remodeling and pro-inflammatory responses, whereas proteomics-based gene set enrichment analysis pinpointed metabolic pathway perturbations. Integration with single-cell RNA-sequencing data identified key regulated cell types involved in development of NASH demonstrating the cellular heterogeneity and complexity of NASH pathogenesis.
引用
收藏
相关论文
共 382 条
  • [1] McPherson Stuart(2015)Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management Journal of Hepatology 62 1148-1155
  • [2] Hardy Tim(2015)Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies Clinical Gastroenterology and Hepatology 13 643-654.e9-2257
  • [3] Henderson Elsbeth(2015)Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis Gastroenterology 149 367-378.e5-1321
  • [4] Burt Alastair D.(2019)Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis Hepatology 69 2241-1759
  • [5] Day Christopher P.(2005)Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 1313-1465
  • [6] Anstee Quentin M.(2012)Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients Hepatology 56 1751-636
  • [7] Singh Siddharth(2008)Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nature Genetics 40 1461-180
  • [8] Allen Alina M.(2014)A 4-Polymorphism Risk Score Predicts Steatohepatitis in Children With Nonalcoholic Fatty Liver Disease Journal of Pediatric Gastroenterology and Nutrition 58 632-1106
  • [9] Wang Zhen(2016)The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent Gastroenterology 150 1219-1230.e6-13
  • [10] Prokop Larry J.(2013)The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study Atherosclerosis 228 175-G472